PROVIGIL

This brand name is authorized in Estonia, Ireland, Israel, Malta, United Kingdom, United States, South Africa

Active ingredients

The drug PROVIGIL contains one active pharmaceutical ingredient (API):

1 Modafinil UNII R3UK8X3U3D - MODAFINIL

Modafinil promotes wakefulness in a variety of species, including man. The precise mechanism(s) through which modafinil promotes wakefulness is unknown. Read about Modafinil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PROVIGIL Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BA07	Modafinil	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1826490
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139495, 143788, 36823
Country: IE	Health Products Regulatory Authority	Identifier(s): 43460, 44515
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6836
Country: MT	Medicines Authority	Identifier(s): AA565/46601
Country: US	FDA, National Drug Code	Identifier(s): 63459-101, 63459-201
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/1.1/0025